Opinion: Why CT must tackle the PBM problem. Feb 17 Written by Jonathan Karush Jonathan Karush Previous Previous Face the Facts: Breaking down the cost of prescription drugs Next Next US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
